GlassScriptPhysician profile
James I Klepper
NPI 1043303233
$16,065.83
in general payments reported to CMS, 2019-2025
57 companies · $1,732 in 2025
The $1,732 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,750 · 2020: $2,075 · 2021: $3,335 · 2022: $2,449 · 2023: $1,975 · 2024: $1,750 · 2025: $1,732.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,438 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,437.99 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $1,500.06 | 2019-2024 | |
| Amgen INC. | $1,378.92 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,298.92 | 2019-2025 | |
| Novo Nordisk INC | $1,267.72 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $1,006.40 | 2019-2025 | Verquvo, Gardasil 9, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $889.33 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $803.05 | 2019-2024 | Xarelto |
| Amarin Pharma, INC. | $790.22 | 2019-2023 | |
| Abbott Laboratories | $785.99 | 2020-2024 | Cardiomems |
| Pfizer INC. | $668.69 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $474.07 | 2019-2025 | Farxiga, Wainua, Airsupra |
| Esperion Therapeutics, INC. | $458.42 | 2020-2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $436.17 | 2019-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $337.84 | 2019-2025 | Camzyos, Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $293.34 | 2022-2025 |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $269.40 | 2019-2023 | Lexiscan |
| Arbor Pharmaceuticals, INC. | $266.18 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $256.35 | 2019-2024 | Evkeeza |
| Eisai INC. | $212.27 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $197.84 | 2022-2023 | Quviviq |
| Abbvie INC. | $195.46 | 2019-2025 | |
| Boston Scientific Corporation | $192.77 | 2019-2025 | Watchman Flx |
| Glaxosmithkline, LLC. | $184.03 | 2020-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Edwards Lifesciences Corporation | $181.85 | 2022 | |
| Azurity Pharmaceuticals, INC. | $157.09 | 2023-2025 | Edarbi, Edarbyclor, Horizant |
| Genzyme Corporation | $125.00 | 2019 | |
| Lilly USA, LLC | $119.50 | 2019-2024 | Mounjaro, Zepbound |
| Sanofi Pasteur INC. | $116.80 | 2019-2024 | |
| Kowa Pharmaceuticals America, INC. | $100.60 | 2019-2023 | Livalo, Seglentis |
| United Therapeutics Corporation | $100.00 | 2020 | |
| Scpharmaceuticals INC. | $76.68 | 2024-2025 | |
| Daiichi Sankyo INC. | $72.71 | 2023-2024 | Injectafer |
| Exact Sciences Corporation | $58.52 | 2023-2024 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $57.74 | 2025 | Gemtesa |
| Lundbeck LLC | $57.49 | 2019-2020 | |
| Currax Pharmaceuticals LLC | $57.09 | 2019-2020 | |
| Inspire Medical Systems, INC. | $49.62 | 2024-2025 | Inspire |
| Medtronic, INC. | $48.26 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $45.05 | 2023 | Arcalyst |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.94 | 2024 | Cycloset |
| Shield Therapeutics INC | $39.70 | 2023 | Accrufer |
| Atricure, INC. | $39.47 | 2019 | |
| Gilead Sciences, INC. | $37.91 | 2019 | |
| Heartflow, INC. | $37.76 | 2025 | |
| Bardy Diagnostics, INC. | $37.35 | 2022 | |
| Kestra Medical Technology Services, INC. | $29.83 | 2024 | Assure Wcd |
| Tandem Diabetes Care, INC. | $28.23 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Lexicon Pharmaceuticals, INC. | $23.91 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $23.12 | 2024 | Arcalyst |
| Amryt Pharma Holdings LTD | $22.53 | 2021 | |
| Intra-Sana Laboratories | $21.50 | 2024 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Vifor Pharma, INC. | $20.64 | 2019 | |
| Seqirus USA INC | $17.99 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Althera Pharmaceuticals LLC | $16.91 | 2021 | |
| Ibsa Pharma INC. | $14.27 | 2025 | Tirosint, Licart, Flector |
| Takeda Pharmaceuticals U.S.A., INC. | $13.25 | 2019 | |
| Vistapharm, INC. | $13.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Klepper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.